ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P ASX 200
8,436.20
-0.10%
S&P ASX All Technology
3,964.00
0.35%
Brent Oil
72.265
-0.56%
US Dollar vs AUD
1.5373
0.03%
Bitcoin
97,120.80
1.53%
Pepperstone
Advertisement
Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. Canada
  5. TSX
  6. Crescita Therapeutics Inc (CTX)

  7. Crescita Therapeutics Inc (CTX) News

CTX

Crescita Therapeutics (CTX)

Crescita Therapeutics Inc
Date:
Sort by:
 Showing the most relevant articles for your search:TSX:CTX
DateTimeSourceHeadlineSymbolCompany
01/06/202319:00PR Newswire (Canada)Croma-Pharma: Launch of topical anaesthetic Pliaglis® in EuropeTSX:CTXCrescita Therapeutics Inc
01/06/202319:00PR Newswire (US)Croma-Pharma: Launch of topical anaesthetic Pliaglis® in EuropeTSX:CTXCrescita Therapeutics Inc
01/06/202319:00PR Newswire (US)Croma-Pharma: Launch of topical anaesthetic Pliaglis® in EuropeTSX:CTXCrescita Therapeutics Inc
21/01/202123:30PR Newswire (US)Crescita Announces Filing of New Medical Device LicenseTSX:CTXCrescita Therapeutics Inc
21/01/202123:30PR Newswire (Canada)Crescita Announces Filing of New Medical Device LicenseTSX:CTXCrescita Therapeutics Inc
26/11/202023:30PR Newswire (Canada)Crescita Therapeutics Announces Approval of Normal Course Issuer BidTSX:CTXCrescita Therapeutics Inc
26/11/202023:30PR Newswire (US)Crescita Therapeutics Announces Approval of Normal Course Issuer BidTSX:CTXCrescita Therapeutics Inc
12/11/202023:30PR Newswire (Canada)Crescita Reports Third Quarter 2020 ResultsTSX:CTXCrescita Therapeutics Inc
12/11/202023:30PR Newswire (US)Crescita Reports Third Quarter 2020 ResultsTSX:CTXCrescita Therapeutics Inc
05/11/202023:30PR Newswire (Canada)Crescita Announces Licensing Agreement for Pliaglis® in ChinaTSX:CTXCrescita Therapeutics Inc
05/11/202023:30PR Newswire (US)Crescita Announces Licensing Agreement for Pliaglis® in ChinaTSX:CTXCrescita Therapeutics Inc
12/08/202021:30PR Newswire (US)Crescita Reports Second Quarter 2020 ResultsTSX:CTXCrescita Therapeutics Inc
12/08/202021:30PR Newswire (Canada)Crescita Reports Second Quarter 2020 ResultsTSX:CTXCrescita Therapeutics Inc
28/07/202021:30PR Newswire (US)Crescita to Receive One-time Cash Payment Following Amendment to Pliaglis® U.S. Licensing AgreementTSX:CTXCrescita Therapeutics Inc
28/07/202021:30PR Newswire (Canada)Crescita to Receive One-time Cash Payment Following Amendment to Pliaglis® U.S. Licensing AgreementTSX:CTXCrescita Therapeutics Inc
27/05/202021:30PR Newswire (US)Crescita Reports First Quarter 2020 ResultsTSX:CTXCrescita Therapeutics Inc
27/05/202021:30PR Newswire (Canada)Crescita Reports First Quarter 2020 ResultsTSX:CTXCrescita Therapeutics Inc
14/05/202022:30PR Newswire (US)Crescita Therapeutics Announces the Results of its Annual General Meeting of ShareholdersTSX:CTXCrescita Therapeutics Inc
14/05/202022:30PR Newswire (Canada)Crescita Therapeutics Announces the Results of its Annual General Meeting of ShareholdersTSX:CTXCrescita Therapeutics Inc
29/04/202007:58PR Newswire (US)Crescita Therapeutics Announces Extension of First Quarter 2020 Filings Due to COVID-19TSX:CTXCrescita Therapeutics Inc
29/04/202007:58PR Newswire (Canada)Crescita Therapeutics Announces Extension of First Quarter 2020 Filings Due to COVID-19TSX:CTXCrescita Therapeutics Inc
25/03/202010:23PR Newswire (US)Crescita Therapeutics Announces Measures in Response to COVID-19 VirusTSX:CTXCrescita Therapeutics Inc
25/03/202010:23PR Newswire (Canada)Crescita Therapeutics Announces Measures in Response to COVID-19 VirusTSX:CTXCrescita Therapeutics Inc
18/03/202022:30PR Newswire (US)Crescita Reports Q4 and Fiscal 2019 ResultsTSX:CTXCrescita Therapeutics Inc
18/03/202022:30PR Newswire (Canada)Crescita Reports Q4 and Fiscal 2019 ResultsTSX:CTXCrescita Therapeutics Inc
11/03/202000:30PR Newswire (Canada)Pliaglis® finally available in CanadaTSX:CTXCrescita Therapeutics Inc
11/03/202000:30PR Newswire (Canada)Pliaglis® enfin disponible au CanadaTSX:CTXCrescita Therapeutics Inc
11/02/202023:30PR Newswire (US)Crescita Announces Positive Topline Results from Two Pivotal Phase 3 Clinical Studies for its Lead Pipeline Product in Patien...TSX:CTXCrescita Therapeutics Inc
11/02/202023:30PR Newswire (Canada)Crescita Announces Positive Topline Results from Two Pivotal Phase 3 Clinical Studies for its Lead Pipeline Product in Patien...TSX:CTXCrescita Therapeutics Inc
24/01/202023:30PR Newswire (US)Crescita Awarded Cannabis Research License from Health CanadaTSX:CTXCrescita Therapeutics Inc
 Showing the most relevant articles for your search:TSX:CTX

Your Recent History

ASX
NCM
Newcrest Mining
FX
AUDUSD
AUD vs US Dollar
PM
XAUUSD
Gold vs US Dollar
ASX
WDC
Westfield
COIN
ADAUSD
Cardano
ASX
BHP
BHP
NASDAQ
AAPL
Apple
NYSE
XOM
Exxon Mobil
NYSE
MRK
Merck
ASX
WOW
Woolworths
COIN
AVAXUSD
Avalanche
COIN
XRPUSD
Ripple
NYSE
NKE
Nike
COIN
BTCUSD
Bitcoin
ASX
WBC
Westpac Banking
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Australia
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved

BLACK FRIDAY

ADVFN

Celebrating 25 years Est 1999-2024

Save up to 60%* for ASX Level 1 & 2

1 year 40%, 2 years 40% and *3 years 60%

*Across 3 years $1958.40 only $783.36